Scientific background
A comprehensive set of studies was conducted on NeOpuntia® in order to confirm its lipophilic properties. The latest clinical study goes even further: it also reveals its health benefits related to blood lipid levels regulation.
Lipophilic properties
-
In vitro tests simulating gastro-intestinal conditions showed that :
- NeOpuntia® could decrease fatty acid bioavailability by more than 28%.
- NeOpuntia® lipophilic capacity is much higher than the one of Chitosan
- A pilot clinical study also suggests that 1.6 g of NeOpuntia® per meal increases fat excretion on an average of 27%, compared to placebo.
Beyond weight management , for further health benefits...
- Nexira conducted a larger study designed to assess NeOpuntia®'s ability to manage 5 risk factors typically associated with Metabolic Syndrome (Syndrome X).
The study highlights that, along with a balanced diet and regular physical exercise,
1.6g of NeOpuntia® per meal could help to :
- Regulate some blood lipid parameters, which are generally associated with reduced cardio-vascular risks.
- Positively influence Syndrome X diagnosis.
- The results of this study are published : E. Linares et al. "The effect of NeOpuntia® on blood lipid parameters - Risk factors for the Metabolic Syndrome (Syndrome X)". Advances in Therapy Vol. 24; No.5, September/October 2007; (1113-1123 ).
» Feel free to contact us to get detailed results of the studies.
